Sanofi

ORG Health Care / Pharmaceuticals Momentum 9.2 NORMAL Primary: Spectral Shift

$65B revenue (Paris) manufactures vaccines, oncology, and specialty pharma across 100+ countries. Divested French fill-finish site to Adragos Pharma in Q1 2026 as part of portfolio streamlining.

Divested sterile fill-finish manufacturing site in France to Adragos Pharma; active portfolio optimization and manufacturing footprint rationalization.
0.00
PSI Score
9.2
Momentum
0%
Confidence
3
Connections
Connected Entities
Merck AstraZeneca Novo Nordisk
Watch This Entity
PSI Intelligence
30-Day Trend
2026-03-20 2026-04-17 17 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.136
Narrative Drift
0.000
Spectral Shift
831.349
Sentiment-Momentum Divergence
0.000
Source Concentration
0.773
Network Analysis
3 Degree Centrality
Centrality History
2026-03-20 2026-04-17 17 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 4 NEW
AstraZeneca 2 NEW
Novo Nordisk 1 NEW
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-04-17 ← Intelligence Network